EDQM updates policy for pharma on CEP suspension/withdrawal/application closure
This article was originally published in SRA
Executive Summary
The European Directorate for the Quality of Medicines & Healthcare (EDQM) has adopted a revised policy on suspending and withdrawing certificates of suitability (CEPs) and for the closure (or cancellation) of ongoing CEP applications1,2.